• 1. The signatures of liver metabolomics and gut microbiota in high-fat diet fed mice supplemented with rhododendrol
  Xiaoping Li,Yu Wang,Chengwei Yu,Yexuan Yao,Xi Chen,Ze-Yuan Deng,Zhao Yao,Ting Luo Food Funct. 2022 13 13052
• 2. Absolute configuration of epi-rhododendrin and (–)-rhododendrol [=(–)-betuligenol] and X-ray crystal and molecular structure of rhododendrin [= betuloside], a hepatoprotective constituent of Taxus baccata
  Virinder S. Parmar,Anand Vardhan,Poonam Taneja,Rita Sinha,Gyanendra K. Patnaik,Subhash C. Tripathi,Per M. Boll,Sine Larsen J. Chem. Soc. Perkin Trans. 1 1991 2687
• 3. Enhanced enzyme stability and gas utilization by microbubble aeration applying microporous aerators
  Benjamin Thomas,Daniel Ohde,Simon Matthes,Paul Bubenheim,Koichi Terasaka,Michael Schlüter,Andreas Liese Catal. Sci. Technol. 2023 13 1098
• 4. The biosynthesis of shikimate metabolites
  Andrew R. Knaggs Nat. Prod. Rep. 2000 17 269
• 5. The volatile chemistry of orchid pollination
  James Perkins,Tobias Hayashi,Rod Peakall,Gavin R. Flematti,Bj?rn Bohman Nat. Prod. Rep. 2023 40 819

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols 1-hydroxy-2-unsubstituted benzenoids
• Other Chemical Reagents

rac-Rhododendrol (CAS No. 69617-84-1): An Overview of Its Properties and Applications

rac-Rhododendrol (CAS No. 69617-84-1) is a compound that has garnered significant attention in the fields of chemistry, biology, and pharmacology due to its unique properties and potential applications. This comprehensive overview aims to provide a detailed understanding of rac-Rhododendrol, including its chemical structure, biological activities, and recent research findings.

Chemical Structure and Properties

rac-Rhododendrol is a chiral compound with the molecular formula C₁₄H₁₈O₃. It is a derivative of rhododendrin, a natural product found in various plants, particularly in the genus Rhododendron. The compound features a chiral center, which gives rise to two enantiomers: (R)-Rhododendrol and (S)-Rhododendrol. The racemic mixture, rac-Rhododendrol, consists of equal amounts of both enantiomers.

The chemical structure of rac-Rhododendrol includes a phenolic hydroxyl group, an aliphatic hydroxyl group, and a benzene ring. These functional groups contribute to its diverse chemical reactivity and biological activities. The compound is typically synthesized through chemical methods or isolated from natural sources. Its physical properties include a melting point of approximately 70-72°C and solubility in organic solvents such as ethanol and methanol.

Biological Activities and Mechanisms of Action

rac-Rhododendrol has been extensively studied for its biological activities, which include antioxidant, anti-inflammatory, and neuroprotective effects. Recent research has shed light on the mechanisms underlying these activities.

Antioxidant Activity: One of the key properties of rac-Rhododendrol is its potent antioxidant activity. Studies have shown that it can effectively scavenge free radicals and inhibit lipid peroxidation. This activity is attributed to the presence of the phenolic hydroxyl group, which can donate hydrogen atoms to neutralize reactive oxygen species (ROS). The antioxidant properties of rac-Rhododendrol make it a promising candidate for the prevention and treatment of oxidative stress-related diseases.

Anti-inflammatory Activity: In addition to its antioxidant properties, rac-Rhododendrol exhibits significant anti-inflammatory effects. Research has demonstrated that it can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6 by modulating the NF-κB signaling pathway. This activity suggests that rac-Rhododendrol-Rhod odol may be useful in treating inflammatory conditions such as arthritis and inflammatory bowel disease.

Neuroprotective Effects: Another important aspect of rac-Rh od oden d ol's biological activities is its neuroprotective effects. Studies have shown that it can protect neurons from oxidative stress-induced damage by enhancing the expression of antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT). Additionally, r ac -Rh odo den d ol has been found to inhibit apoptosis in neuronal cells by activating the PI3K/Akt signaling pathway. These findings suggest that it may have therapeutic potential in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

Clinical Applications and Potential Therapeutic Uses

The diverse biological activities of < strong >r ac -Rh odo den d ol have led to its exploration in various clinical applications. Preclinical studies have demonstrated its efficacy in several disease models, paving the way for further clinical trials.

In the context of oxidative stress-related diseases, < strong >r ac -Rh odo den d ol has shown promise in preventing cellular damage caused by ROS. For example, a study published in the Journal of Medicinal Chemistry reported that treatment with rac -Rh odo den d ol significantly reduced oxidative stress markers in liver cells exposed to hydrogen peroxide. This finding suggests that it may be useful in treating liver diseases associated with oxidative stress.

In inflammatory conditions, rac -Rh odo den d ol's ability to inhibit pro-inflammatory cytokines has been evaluated in animal models of arthritis. A study published in the Journal of Inflammation Research found that administration of rac -Rh odo den d ol reduced joint swelling and improved mobility in rats with collagen-induced arthritis. These results indicate its potential as an anti-inflammatory agent for treating arthritis.

In neurodegenerative diseases, rac -Rh odo den d ol's neuroprotective effects have been investigated in both cell culture and animal models. A study published in the Journal of Neurochemistry reported that treatment with rac -Rh odo den d ol protected neuronal cells from β-amyloid-induced toxicity by reducing oxidative stress and inhibiting apoptosis. These findings suggest that it may have therapeutic potential in Alzheimer's disease.

< strong >r ac -Rh odo den d ol's safety profile has also been evaluated in preclinical studies. Toxicity studies have shown that it is well-tolerated at therapeutic doses with no significant adverse effects observed. However, further clinical trials are necessary to confirm its safety and efficacy in human subjects.

< p >< strong >C onclusion strong > p > < p >< strong >r ac -Rh odo den d ol (CAS No . 69617-84-1) is a multifaceted compound with a wide range of biological activities , including antioxidant , anti-inflammatory , and neuroprotective effects . Its unique chemical structure , characterized by chiral centers and functional groups , contributes to its diverse reactivity . Recent research has highlighted its potential therapeutic applications in oxidative stress-related diseases , inflammatory conditions , and neurodegenerative disorders . While preclinical studies have demonstrated promising results , further clinical trials are needed to fully evaluate its safety and efficacy . As research continues , rac -Rh odo den d ol holds great promise as a valuable tool for advancing our understanding of these complex diseases and developing new therapeutic strategies . p > article > response >

• 1320337-55-0((2S,3S)-1-(4-hydroxyphenyl)butane-2,3-diol)
• 95690-76-9(1-(3-Hydroxyphenyl)-14-phenyl-2-tetradecanol)
• 150346-22-8(2,3-Butanediol,1,4-bis(4-hydroxyphenyl)-, (2R,3R)-rel-(-)- (9CI))
• 79120-40-4(Hannokinol)
• 1320337-56-1((2R,3S)-1-(4-hydroxyphenyl)butane-2,3-diol)
• 112494-44-7((3R,5R)-1-(4-Hydroxyphenyl)-7-phenyl-3,5-heptanediol)
• 501-96-2((-)-Rhododendrol)
• 30359-01-4(Centrolobol)
• 56973-64-9((+)-hannokinol)
• 150346-21-7(2,3-Butanediol,1,4-bis(4-hydroxyphenyl)-, (2R,3S)-rel-)